• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿脂联素水平升高与择期经皮冠状动脉介入治疗患者的造影剂肾病相关。

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.

机构信息

Department of Cardiology, Xijing Hospital, Fourth Military Medical University, 15 Changle West Road, Xi'an, 710032, Shannxi, China.

出版信息

BMC Cardiovasc Disord. 2019 Jul 3;19(1):160. doi: 10.1186/s12872-019-1143-y.

DOI:10.1186/s12872-019-1143-y
PMID:31269899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610850/
Abstract

BACKGROUND

Contrast-induced nephropathy (CIN) is one of major and serious complications in patients undergoing percutaneous coronary intervention (PCI). It is unknown whether increased urinary adiponectin (UAPN), a sensitive marker for early renal function impairment, is associated with an increased risk of CIN. Therefore, we prospectively investigate the association of UAPN with CIN.

METHODS

We prospectively enrolled 208 patients who were undergoing elective PCI. The baseline UAPN was assessed prior to PCI. The ROC analysis was used to evaluate the predictive value of UAPN for CIN. Multivariate logistic regression analysis was performed to analyze the independent risk factors for CIN.

RESULTS

Of 208 patients, CIN occurred in 19 patients (9.13%), and 6 of them (2.88%) required dialysis. Patients with CIN had a higher UAPN level than those without CIN (17.15 ± 12.36 vs. 10.29 ± 3.04 ng/ml, P < 0.01). ROC analysis showed that the optimal cutoff value of UAPN for predicting CIN was 12.24 ng/ml with 68.42% sensitivity and 76.72% specificity (AUC = 0.7204; 95% CI, 0.582-0.859; 푃< 0.01). Multivariate analysis demonstrated that UAPN (OR, 5.071; 95% CI,1.711-15.028; P < 0.01) and serum creatinine (Scr) > 124 μmol/L (OR, 4.210; 95% CI, 1.297-13.669; P < 0.01) were independently associated with CIN.

CONCLUSIONS

Our present study showed that a higher baseline UAPN (≥12.24 ng/ml) level was significantly associated with an increased risk for developing CIN post PCI.

摘要

背景

对比剂诱导的肾病(CIN)是经皮冠状动脉介入治疗(PCI)患者的主要且严重的并发症之一。目前尚不清楚尿脂联素(UAPN)的升高是否与 CIN 风险增加有关,UAPN 是早期肾功能损害的敏感标志物。因此,我们前瞻性地研究了 UAPN 与 CIN 的关系。

方法

我们前瞻性地纳入了 208 例行择期 PCI 的患者。在 PCI 前评估基线 UAPN。ROC 分析用于评估 UAPN 预测 CIN 的价值。多变量 logistic 回归分析用于分析 CIN 的独立危险因素。

结果

208 例患者中,19 例(9.13%)发生 CIN,其中 6 例(2.88%)需要透析。发生 CIN 的患者 UAPN 水平高于未发生 CIN 的患者(17.15±12.36 vs. 10.29±3.04ng/ml,P<0.01)。ROC 分析显示,UAPN 预测 CIN 的最佳截断值为 12.24ng/ml,灵敏度为 68.42%,特异性为 76.72%(AUC=0.7204;95%CI,0.582-0.859;P<0.01)。多变量分析表明,UAPN(OR,5.071;95%CI,1.711-15.028;P<0.01)和血清肌酐(Scr)>124μmol/L(OR,4.210;95%CI,1.297-13.669;P<0.01)与 CIN 独立相关。

结论

本研究表明,较高的基线 UAPN(≥12.24ng/ml)水平与 PCI 后发生 CIN 的风险增加显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95e/6610850/ba5171406ad1/12872_2019_1143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95e/6610850/0cce8b1ec7ce/12872_2019_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95e/6610850/ba5171406ad1/12872_2019_1143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95e/6610850/0cce8b1ec7ce/12872_2019_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95e/6610850/ba5171406ad1/12872_2019_1143_Fig2_HTML.jpg

相似文献

1
Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.尿脂联素水平升高与择期经皮冠状动脉介入治疗患者的造影剂肾病相关。
BMC Cardiovasc Disord. 2019 Jul 3;19(1):160. doi: 10.1186/s12872-019-1143-y.
2
A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.用于预测糖尿病患者冠状动脉造影后对比剂诱导肾病的简单风险评分模型。
Clin Exp Nephrol. 2019 Jul;23(7):969-981. doi: 10.1007/s10157-019-01739-0. Epub 2019 May 2.
3
Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.接受冠状动脉造影术(无论是否进行经皮冠状动脉介入治疗)患者的血容量与肌酐清除率比值:对比剂肾病不同定义的影响
Catheter Cardiovasc Interv. 2014 May 1;83(6):907-12. doi: 10.1002/ccd.25153. Epub 2013 Aug 31.
4
The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.肾阻力指数对急性冠脉综合征患者对比剂肾病的预测价值。
BMC Cardiovasc Disord. 2019 Feb 11;19(1):36. doi: 10.1186/s12872-019-1017-3.
5
Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.高敏 C 反应蛋白联合降钙素原预测经皮冠状动脉介入治疗后对比剂诱导肾病的高危风险。
BMC Cardiovasc Disord. 2019 Jun 24;19(1):152. doi: 10.1186/s12872-019-1137-9.
6
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.CHA2DS2-VASC评分作为慢性完全闭塞患者经皮冠状动脉介入治疗中对比剂肾病的术前预测指标:单中心经验
BMC Cardiovasc Disord. 2019 Mar 29;19(1):74. doi: 10.1186/s12872-019-1060-0.
7
Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.红细胞分布宽度可预测急性冠状动脉综合征患者接受经皮冠状动脉介入治疗时发生的对比剂肾病。
Angiology. 2015 May;66(5):433-40. doi: 10.1177/0003319714535238. Epub 2014 May 16.
8
Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.前列地尔预防经皮冠状动脉介入治疗患者造影剂肾病的疗效:一项多中心前瞻性随机对照试验。
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):742-750. doi: 10.1002/ccd.27353. Epub 2017 Oct 10.
9
Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.非糖尿病患者择期经皮冠状动脉介入治疗后代谢综合征对造影剂肾病发生的影响。
Clin Cardiol. 2015 Mar;38(3):150-6. doi: 10.1002/clc.22364.
10
Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.血清渗透压作为择期冠状动脉造影后对比剂肾病的潜在预测因子。
Int Urol Nephrol. 2020 Mar;52(3):541-547. doi: 10.1007/s11255-020-02391-4. Epub 2020 Feb 1.

引用本文的文献

1
Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.经皮冠状动脉介入治疗后对比剂肾病的危险因素:一项回顾性分析
J Int Med Res. 2021 Apr;49(4):3000605211005972. doi: 10.1177/03000605211005972.

本文引用的文献

1
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.脂联素,肥胖、糖尿病及内皮功能障碍的治疗靶点。
Int J Mol Sci. 2017 Jun 21;18(6):1321. doi: 10.3390/ijms18061321.
2
Understanding and preventing contrast-induced acute kidney injury.理解并预防对比剂诱导的急性肾损伤。
Nat Rev Nephrol. 2017 Mar;13(3):169-180. doi: 10.1038/nrneph.2016.196. Epub 2017 Jan 31.
3
Underestimated incidence of kidney disease in nonrenal outpatient.非肾脏科门诊患者中被低估的肾脏疾病发病率。
Ren Fail. 2017 Nov;39(1):328-332. doi: 10.1080/0886022X.2017.1279551.
4
Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.慢性肾脏病患者冠状动脉造影中造影剂的使用:随机试验的系统评价和荟萃分析
Int J Cardiol. 2017 Feb 1;228:137-144. doi: 10.1016/j.ijcard.2016.11.170. Epub 2016 Nov 9.
5
Preprocedural High-Sensitivity C-Reactive Protein Predicts Contrast-Induced Nephropathy and Long-Term Outcome After Coronary Angiography.术前高敏C反应蛋白可预测冠状动脉造影术后对比剂肾病及长期预后。
Angiology. 2017 Aug;68(7):614-620. doi: 10.1177/0003319716674623. Epub 2016 Oct 25.
6
Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.尿脂联素是 1 型糖尿病合并糖尿病肾病患者进展至终末期肾病的独立预测因子。
Diabetes Care. 2015 May;38(5):883-90. doi: 10.2337/dc14-2276. Epub 2015 Feb 26.
7
Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?胱抑素C在急性肾损伤诊断中的应用:早期生物标志物还是血清肌酐的替代指标?
Pediatr Nephrol. 2015 Apr;30(4):665-76. doi: 10.1007/s00467-014-2987-0. Epub 2014 Dec 5.
8
Contrast-induced nephropathy; A literature review.对比剂肾病:文献综述
J Nephropathol. 2014;3(2):51-6. doi: 10.12860/jnp.2014.12. Epub 2014 Apr 1.
9
Contrast-induced kidney injury: mechanisms, risk factors, and prevention.对比剂诱导的肾损伤:机制、危险因素与预防。
Eur Heart J. 2012 Aug;33(16):2007-15. doi: 10.1093/eurheartj/ehr494. Epub 2012 Jan 19.
10
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南。美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.